Attached files
| file | filename |
|---|---|
| EX-23.1 - EX-23.1 - Larimar Therapeutics, Inc. | d138931dex231.htm |
| EX-31.2 - EX-31.2 - Larimar Therapeutics, Inc. | d138931dex312.htm |
| EX-31.1 - EX-31.1 - Larimar Therapeutics, Inc. | d138931dex311.htm |
| EX-10.16 - EX-10.16 - Larimar Therapeutics, Inc. | d138931dex1016.htm |
| 10-K - 10-K - Larimar Therapeutics, Inc. | d138931d10k.htm |
Exhibit 32.1
CERTIFICATIONS UNDER SECTION 906
Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Zafgen, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:
The Annual Report for the year ended December 31, 2015 (the “Form 10-K”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.
| Dated: March 15, 2016 |
/s/ Thomas E. Hughes | |
|
| ||
| Thomas E. Hughes | ||
| Chief Executive Officer | ||
| (Principal Executive Officer) | ||
| Dated: March 15, 2016 |
/s/ Patricia Allen | |
|
| ||
| Patricia Allen | ||
| Chief Financial Officer (Principal Financial and Accounting Officer) | ||